These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 2467541

  • 1. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [Abstract] [Full Text] [Related]

  • 2. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M, Kitamura Y, Komatsubara S, Sakata Y.
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [Abstract] [Full Text] [Related]

  • 3. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [Abstract] [Full Text] [Related]

  • 4. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S.
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [Abstract] [Full Text] [Related]

  • 5. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
    Hasegawa S, Nakashima J, Nakashima Y, Nakamura S, Kimura S.
    Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T, Okada K, Oishi K, Yoshida O.
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [Abstract] [Full Text] [Related]

  • 7. [The significance of serum gamma-seminoprotein in prostatic cancer].
    Ishikawa S, Tozuka K, Ishiyama S, Goto K, Ohba S, Tokue A, Yonese Y, Kamachi S, Sakurabayashi I, Kawai T.
    Hinyokika Kiyo; 1985 Jun; 31(6):961-7. PubMed ID: 2414979
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
    Ishihara Y, Hiromoto Y, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
    Shinoda I.
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov 20; 25(11):2627-39. PubMed ID: 1703555
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
    Tsukamoto T, Kumamoto Y, Yamazaki K, Umehara T, Miyao N, Ohmura K, Iwazawa M.
    Hinyokika Kiyo; 1988 Jun 20; 34(6):987-95. PubMed ID: 2464917
    [Abstract] [Full Text] [Related]

  • 11. [Clinical study of tumor markers in prostatic cancer].
    Ishihara Y, Fukagai T, Ohta K, Hiromoto Y, Hiramori M, Torii T, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1990 Apr 20; 36(4):425-31. PubMed ID: 1696063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical studies of gamma-seminoprotein in prostatic disease. II. Immunohistochemical study of gamma-seminoprotein].
    Nakashima J, Hasegawa S, Nakashima Y, Nakamura S, Kimura S, Tachibana M, Deguchi N, Tazaki H.
    Hinyokika Kiyo; 1987 Dec 20; 33(12):2059-63. PubMed ID: 3329454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases].
    Uchijima Y, Yoshida K, Saitoh H.
    Hinyokika Kiyo; 1991 Oct 20; 37(10):1255-60. PubMed ID: 1721770
    [Abstract] [Full Text] [Related]

  • 18. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G.
    Hinyokika Kiyo; 1983 Oct 20; 29(10):1231-45. PubMed ID: 6085711
    [Abstract] [Full Text] [Related]

  • 19. [Prostate specific antigen in serum of the patients with prostatic cancer].
    Akimoto S, Akakura K, Fuse H, Shimazaki J.
    Hinyokika Kiyo; 1988 Apr 20; 34(4):636-42. PubMed ID: 2456678
    [Abstract] [Full Text] [Related]

  • 20. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S, Akakura K, Masai M, Isaka S, Shimazaki J.
    Hinyokika Kiyo; 1990 Jul 20; 36(7):783-91. PubMed ID: 1700588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.